[go: up one dir, main page]

WO1999047655A3 - Menschliche nukleinsaeurefragmente, deren expression in brustnormalgewebe erhöht ist - Google Patents

Menschliche nukleinsaeurefragmente, deren expression in brustnormalgewebe erhöht ist Download PDF

Info

Publication number
WO1999047655A3
WO1999047655A3 PCT/DE1999/000909 DE9900909W WO9947655A3 WO 1999047655 A3 WO1999047655 A3 WO 1999047655A3 DE 9900909 W DE9900909 W DE 9900909W WO 9947655 A3 WO9947655 A3 WO 9947655A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
breast tissue
human nucleic
acid fragments
normal breast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE1999/000909
Other languages
English (en)
French (fr)
Other versions
WO1999047655A2 (de
Inventor
Thomas Specht
Bernd Hinzmann
Armin Schmitt
Christian Pilarsky
Edgar Dahl
Andre Rosenthal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
METAGEN GESELLSCHAFT fur GENOMFORSCHUNG MBH
Original Assignee
METAGEN GESELLSCHAFT fur GENOMFORSCHUNG MBH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by METAGEN GESELLSCHAFT fur GENOMFORSCHUNG MBH filed Critical METAGEN GESELLSCHAFT fur GENOMFORSCHUNG MBH
Priority to EP99924684A priority Critical patent/EP1070125A2/de
Priority to JP2000536838A priority patent/JP2002506639A/ja
Publication of WO1999047655A2 publication Critical patent/WO1999047655A2/de
Publication of WO1999047655A3 publication Critical patent/WO1999047655A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Es werden menschliche Nukleinsäuresequenzen - mRNA, cDNA, genomische Sequenzen - aus Brustgewebe, die für Genprodukte oder Teile davon kodieren, und deren Verwendung beschrieben. Es werden weiterhin die über die Sequenzen erhältlichen Polypeptide und deren Verwendung beschrieben.
PCT/DE1999/000909 1998-03-20 1999-03-19 Menschliche nukleinsaeurefragmente, deren expression in brustnormalgewebe erhöht ist Ceased WO1999047655A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP99924684A EP1070125A2 (de) 1998-03-20 1999-03-19 Menchliche nukleinsaeurefragmente, deren expression in brustnormalgewebe erhoeht ist
JP2000536838A JP2002506639A (ja) 1998-03-20 1999-03-19 ヒト正常乳房組織からのヒト核酸配列

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19813835A DE19813835A1 (de) 1998-03-20 1998-03-20 Menschliche Nukleinsäuresequenzen aus Brustnormalgewebe
DE19813835.0 1998-03-20

Publications (2)

Publication Number Publication Date
WO1999047655A2 WO1999047655A2 (de) 1999-09-23
WO1999047655A3 true WO1999047655A3 (de) 2000-07-06

Family

ID=7862720

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1999/000909 Ceased WO1999047655A2 (de) 1998-03-20 1999-03-19 Menschliche nukleinsaeurefragmente, deren expression in brustnormalgewebe erhöht ist

Country Status (4)

Country Link
EP (1) EP1070125A2 (de)
JP (1) JP2002506639A (de)
DE (1) DE19813835A1 (de)
WO (1) WO1999047655A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2320784A1 (en) 1998-02-17 1999-08-19 Institut National De La Sante Et De La Recherche Medicale Members of the d52 gene family
EP1131425A2 (de) * 1998-11-18 2001-09-12 Incyte Pharmaceuticals, Inc. Gene, die mit entzündungen verbunden sind
US6417342B1 (en) * 1999-02-12 2002-07-09 University Of Iowa Research Foundation Macular degeneration diagnostics and therapeutics
US6593104B1 (en) * 1999-02-12 2003-07-15 University Of Iowa Research Foundation Macular degeneration diagnostics and therapeutics
AU775409B2 (en) * 1999-04-30 2004-07-29 Kurokawa, Kiyoshi Meg-3 protein
AU6518700A (en) * 1999-08-03 2001-02-19 Incyte Genomics, Inc. Human chaperone proteins
WO2002008260A2 (en) * 2000-07-26 2002-01-31 Stanford University Bstp-ecg1 protein and related reagents and methods of use thereof
US20050100998A1 (en) * 2000-08-21 2005-05-12 Prescott Stephen M. Human cytidine monophosphate (cmp) kinase cdna
WO2002044367A1 (fr) * 2000-11-29 2002-06-06 Takeda Chemical Industries, Ltd. Procede de criblage de medicaments contre le diabete
US20020119138A1 (en) * 2001-02-26 2002-08-29 Sylvaine Cases Diacylglycerol o-acyltransferase 2alpha (DGAT2alpha)
US8735082B2 (en) 2008-11-10 2014-05-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Gene signature for predicting prognosis of patients with solid tumors

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
BONFIELD, J. ET AL.: "A new sequence assembly program", NUCLEIC ACIDS RESEARCH, vol. 23, 1995, pages 4992 - 4994, XP002127627 *
BRENNER, A.J. ET AL.: "Preferential loss of expression of p16INK4a rather than p19ARF in breast cancer", CLINICAL CANCER RESEARCH, vol. 2, 1996, pages 1993 - 1998, XP002128956 *
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002128961, Database accession no. AA667452 *
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002128962, Database accession no. AA145515 *
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002128963, Database accession no. AA869913 *
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002128964, Database accession no. AA489946 *
HUANG, R.-P. ET AL.: "Decreased Egr-1 expression in human, mouse and rat mamary cells and tissues correlates with tumour formation", INTERNATIONAL JOURNAL OF CANCER, vol. 72, 1997, pages 102 - 109, XP002128955 *
Nishikimi et al. EMBL DATABASE ENTRY AB019219; ACCESSION NUMBER AB019219; 11. Januar 1999 *
NISHIKIMI, A. ET AL.: "A novel mammalian nuclear protein similar to Schizosaccharomyces pombe Prp1/ Zer1p and Saccharomyces cerevisiae Prp6p pre-mRNA splicing factors", BIOCHIMICA BIOPHYSICA ACTA, vol. 1435, 1999, pages 147 - 152, XP000872047 *
SCHMITT, A.O. ET AL.: "Exhaustive mining of EST libraries for genes differentially expressed in normal and tumor tissue", NUCLEIC ACIDS RESEARCH, vol. 27, no. 21, 1 November 1999 (1999-11-01), pages 4251 - 4260, XP002126641 *
SCHULER, G.D.: "Sequence mapping by electronic PCR", GENOME RESEARCH, vol. 7, 1997, pages 541 - 550, XP002127628 *

Also Published As

Publication number Publication date
EP1070125A2 (de) 2001-01-24
DE19813835A1 (de) 1999-09-23
WO1999047655A2 (de) 1999-09-23
JP2002506639A (ja) 2002-03-05

Similar Documents

Publication Publication Date Title
WO1999054461A3 (de) Menschliche nukleinsäuresequenzen aus endometriumtumorgewebe
WO1999047669A3 (de) Menschliche nukleinsäuresequenzen aus brusttumorgewebe
WO1999055858A3 (de) Menschliche nukleinsäuresequenzen aus pankreastumorgewebe
WO1999040189A3 (en) Cdnas encoding secreted proteins
WO1999051727A3 (de) Menschliche nukleinsäuresequenzen aus ovarnormalgewebe
EP1005540A4 (de) Ikk-beta proteines, nukleinsäuren und verfahren
WO1999053051A3 (en) 5' ests and encoded human proteins
WO1999031236A3 (en) EXTENDED cDNAs FOR SECRETED PROTEINS
WO1999025825A3 (en) EXTENDED cDNAs FOR SECRETED PROTEINS
WO1999038972A8 (en) Human genes and gene expression products ii
WO1999054460A3 (de) Menschliche nukleinsäuresequenzen aus normalem blasengewebe
WO1999053040A3 (de) Menschliche nukleinsäuresequenzen aus ovartumorgewebe
WO1999054353A3 (de) Menschliche nukleinsäuresequenzen aus uterusnormalgewebe
WO2000037491A3 (en) Dnas encoding proteins with signal sequences
WO1999047655A3 (de) Menschliche nukleinsaeurefragmente, deren expression in brustnormalgewebe erhöht ist
WO2003048205A3 (fr) Proteines a activite inhibitrice de l'il-6
WO1999054447A3 (de) Menschliche nukleinsäuresequenzen aus blasentumorgewebe
WO2000029623A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO1999046374A3 (de) Menschliche nukleinsäuresequenzen aus prostatatumorgewebe
WO2002010388A3 (en) C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
WO2002050111A3 (en) Isolated laminin 10
WO1999046375A3 (de) Menschliche nukleinsäuresequenzen aus prostatagewebe
WO1999054448A3 (de) Menschliche nukleinsäurefragmente, deren expression in uterusmyomgewebeerhoeht ist
EP1218392A4 (de) Gene die proteine kodieren welche prognostische, diagnostische, präventive, therapeutische und andere verwendungen besitzen
WO2000018916A3 (en) Human genes and gene expression products

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 1999924684

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09646569

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999924684

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999924684

Country of ref document: EP